Management of granulomatous foreign body reaction to fillers with methotrexate.

M BrolyJ MarieC PicardA DemouresC RaimbaultMarie Beylot-Barry Olivier Cogrel

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2019)

Low doses of methotrexate appear to offer a low-risk therapeutic alternative in resistant and severe GFBR to fillers. A prospective study with long-term follow-up is required to confirm these preliminary observations.

Keyphrases

hyaluronic acid
high dose
early onset
interstitial lung disease
low dose
drug induced
idiopathic pulmonary fibrosis